Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ImmunoGen Wants A Bigger Share Of The Antibody-Drug Conjugate Pie

Feb 25 2011

• By Lisa LaMotta

Related Content

Making The Case For Antibody-Drug Conjugates

Dec 01 2010

With Novartis, ImmunoGen Adds $45 Mil. And Another Licensor For Its Antibody-Drug Conjugate Platform

Oct 11 2010

Full Data For Seattle Genetics' Lymphoma Drug Shine Bright Light On Antibody Drug Conjugates

Dec 06 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window